1994
DOI: 10.1051/parasite/1994014319
|View full text |Cite
|
Sign up to set email alerts
|

Action of pentamidine-bound nanoparticles againstLeishmaniaon anin vivomodel

Abstract: Summary :The efficiency of antileishmanial agents may be enhanced by improving their bioavailability with a colloidal drug carrier. We

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

1997
1997
2021
2021

Publication Types

Select...
5
2
1

Relationship

1
7

Authors

Journals

citations
Cited by 25 publications
(9 citation statements)
references
References 3 publications
0
9
0
Order By: Relevance
“…Five female BALB/c mice were infected with 4 × 10 7 promastigotes each and another group of five mice, with 4 × 10 7 pentamidine-resistant promastigotes of L. donovani and L. amazonensis, respectively, by retro-orbital sinus injection (Fusai et al 1994). After 18 days, mice were killed.…”
Section: Stability Of Pentamidine Resistancementioning
confidence: 99%
“…Five female BALB/c mice were infected with 4 × 10 7 promastigotes each and another group of five mice, with 4 × 10 7 pentamidine-resistant promastigotes of L. donovani and L. amazonensis, respectively, by retro-orbital sinus injection (Fusai et al 1994). After 18 days, mice were killed.…”
Section: Stability Of Pentamidine Resistancementioning
confidence: 99%
“…It was found that pentamidine was bound to nanoparticles by ionic interaction. In vitro and in vivo experiments were also performed in order to evaluate the action of pentamidine-bound nanoparticles against intracellular Leishmania [Deniau et al, 1993;Fusaï et al, 1994]. Pentamidine loaded on polymethacrylate was sixfold more active than free drug in Leishmania infantum-infected mice .…”
Section: Introductionmentioning
confidence: 99%
“…Despite the difficulty of access for soluble substances, the phagolysosomes easily accommodate particulate material by vesicle fusion (2,22). This feature is being used as a strategy to increase the bioavailability of drugs and reduce their toxicity (8,14). Amphotericin B has been successfully encapsulated in liposomes, with increased effectiveness and reduced toxicity for visceral (3,5,18,19) and cutaneous (17,23) leishmaniasis patients.…”
mentioning
confidence: 99%